CVT500
Generic Name: ranolazine
Pill imprint CVT500 has been identified as Ranexa 500 mg.
Ranexa is used in the treatment of angina and belongs to the drug class antianginal agents. Risk cannot be ruled out during pregnancy.
Ranexa 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Ranexa Images
- Generic Name:
- ranolazine
- Imprint:
-
CVT500
- Strength:
- 500 mg
- Color:
- Orange
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- carnauba wax
hypromellose 2910 (5 mPa.s)
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
microcrystalline cellulose
sodium hydroxide
polyethylene glycol 400
titanium dioxide
polysorbate 80
FD&C Yellow No. 6
aluminum oxide
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
- Drug Class:
- Antianginal agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- CV Therapeutics, Inc
- National Drug Code (NDC):
- 67159-0112
| NDC Code | Manufacturer / Repackager |
|---|---|
| 61958-1001 | Gilead Sciences, Inc. |
Note: Inactive ingredients may vary.
Advertisement
More Ranexa resources
Search Again
